Dumping Syndrome Unknown Status Phase 2 Trials for Lanreotide (DB06791)

Also known as: Syndromes, Dumping

IndicationStatusPhase
DBCOND0000855 (Dumping Syndrome)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01923649SOMATULINE Autogel 90 mg IN DUMPING SYNDROMETreatment